Albumin-coated paclitaxel-mesoporous silicon nanoparticles APMSN were prepared to improve the anticancer effect in lung cancer by means of regulating the dissolution rate of paclitaxel PTX. PTX was absorbed into the mesoporous structure of mesoporous silicon nanoparticles MSN, which was defined as PMSN. PTX was proved to exist in an amorphous state in PMSN, which increased the dissolution rate of PTX. Albumin was coated on the surface of MSN to form AMSN; AMSN and PTX were mixed to form APMSN in order to achieve sustained release of PTX. Then, it was found that APMSN had more significant antiproliferate effects and induced more apoptotic proportion in comparison with PTX in A549 cells. Furthermore, the absorption mechanism of APMSN into A549 cells was investigated. Transmission electron microscopy TEM and laser scanning confocal microscopy LSCM showed that APMSN could cross the cell membrane and was taken into the cytoplasm quickly. Taken together, our results demonstrate that AMSN carriers have potential as nanodrug delivery systems in the treatment of lung cancer.
Effect of an Albumin-Coated Mesoporous Silicon Nanoparticle Platform for Paclitaxel Delivery in Human Lung Cancer Cell Line A549
Yu Gao,X. Che,Chunlei Zheng,K. Hou,X. Qu,Yunpeng Liu,Zhitu Zhu
Published 2016 in Journal of Nanomaterials
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
Journal of Nanomaterials
- Publication date
2016-10-01
- Fields of study
Medicine, Materials Science
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-21 of 21 references · Page 1 of 1
CITED BY
Showing 1-9 of 9 citing papers · Page 1 of 1